We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

46 hedge funds and large institutions have $24.3M invested in ProQR Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.99% less ownership

Funds ownership: 26.15% → 23.16% (-3%)

10% less funds holding

Funds holding: 51 → 46 (-5)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

29% less capital invested

Capital invested by funds: $34.2M → $24.3M (-$9.91M)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

98% less call options, than puts

Call options by funds: $1K | Put options by funds: $57K

Holders
46
Holders Change
-5
Holders Change %
-9.8%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
10
Closed
9
Calls
$1K
Puts
$57K
Net Calls
-$56K
Net Calls Change
-$233K

Top Buyers

Rank Fund Capital Flow
1
MAM
Monaco Asset Management
Monaco
+$220K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$63.9K
3
GCP
GSA Capital Partners
United Kingdom
+$47.6K
4
Simplex Trading
Simplex Trading
Illinois
+$12.8K
5
Group One Trading
Group One Trading
Illinois
+$9.24K

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$1.06M
2
Deutsche Bank
Deutsche Bank
Germany
-$624K
3
Two Sigma Investments
Two Sigma Investments
New York
-$483K
4
Marshall Wace
Marshall Wace
United Kingdom
-$396K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$25.3K -$2.62K -1,665 -8%
Mariner
27
Mariner
Kansas
$23.8K – – –
Northern Trust
28
Northern Trust
Illinois
$22.6K – – –
Simplex Trading
29
Simplex Trading
Illinois
$19K +$12.8K +8,159 +125%
AI
30
Atom Investors
Texas
$17K – – –
Wells Fargo
31
Wells Fargo
California
$14.3K – – –
UBS Group
32
UBS Group
Switzerland
$13.1K +$8.44K +5,363 +115%
CAG
33
Csenge Advisory Group
Florida
$13K – – –
KAS
34
Kestra Advisory Services
Texas
$13K – – –
Truist Financial
35
Truist Financial
North Carolina
$13K – – –
Vontobel Holding
36
Vontobel Holding
Switzerland
$13K – – –
Group One Trading
37
Group One Trading
Illinois
$12.7K +$9.24K +5,874 +151%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$8.71K -$5.08K -3,226 -32%
Lazard Asset Management
39
Lazard Asset Management
New York
$7K +$475 +302 +5%
BlackRock
40
BlackRock
New York
$5.13K – – –
CG
41
Cutler Group
California
$5K – – –
FAM
42
Flaharty Asset Management
Florida
$2.6K +$3.15K +2,000 New
PP
43
PFS Partners
New Jersey
$1.3K – – –
GWM
44
Geneos Wealth Management
Colorado
$1.3K +$1.57K +1,000 New
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$43 +$52 +33 New
OM
46
Opaleye Management
Massachusetts
– -$1.06M -653,000 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$624K -385,208 Closed
Renaissance Technologies
48
Renaissance Technologies
New York
– -$325K -200,499 Closed
Citadel Advisors
49
Citadel Advisors
Florida
– -$189K -116,792 Closed
CC
50
Centiva Capital
New York
– -$37.5K -23,160 Closed
1
2
3

PRQR Hedge Fund Activity: Q3 2023 in Review

46 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2023, worth a combined $24.3M — down 29% from $34.2M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PRQR and 4 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was Monaco Asset Management, adding an estimated $220K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.06M sold.

  • 46 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2023, down from 51 in Q2 2023.
  • Funds reported $24.3M of ProQR Therapeutics stock for Q3 2023, down 29% quarter-over-quarter.
  • 4 funds opened new ProQR Therapeutics positions in Q3 2023 and 9 closed out, a net change of -5 holders.
  • The largest ProQR Therapeutics buyer in Q3 2023 was Monaco Asset Management, an estimated $220K added.
  • The largest ProQR Therapeutics seller in Q3 2023 was Opaleye Management, an estimated $1.06M sold.

Based on aggregated 13F filings for Q3 2023.